ARCHIVES

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985